Kevin T. Collins represents companies in the life sciences, healthcare, chemical and technology sectors. Clients seek his counsel in connection with SEC registered and privately placed equity and debt financings, mergers and acquisitions, strategic partnering and licensing transactions, corporate governance matters and securities law compliance.

Mr. Collins has led engagement teams on numerous transactions for major healthcare, pharmaceutical, medical device, technology  and chemical companies.  Businesses turn to him to handle significant acquisitions and sales of businesses and assets, strategic partnering and collaboration agreements, initial public offerings, and follow-on public offerings, among other matters.

Mr. Collins is a member of the Mergers & Acquisitions and Securities Practices and the Firm's Alternative Billing Committee.